Literature DB >> 25932214

The effect of polymorphism in DNA repair genes RAD51 and XRCC2 in colorectal cancer in Turkish population.

Suleyman Cetinkunar1, Ilhami Gok2, Ruchan Bahadir Celep3, Dogan Ilhan4, Hasan Erdem1, Bulent Caglar Bilgin5, Recep Aktimur6.   

Abstract

The genes RAD51 and XRCC2 encode proteins that are important for the repair of double-strand DNA breaks by recombination. Therefore, genetic variability in these genes may contribute to the occurrence and progression of carcinoma. We investigated the association of polymorphisms in the DNA repair genes XRCC2-A/G and RAD51-135G/C with the colorectal cancer risk. Genotypes were determined by PCR-RFLP assays in 71 patients with colorectal cancer and 86 age-matched healthy controls. After amplification, we used a restriction enzyme (RAD51; MvaI and XRCC2; HphI) and digested the PCR product. Then, this DNA fragments were passed through gel electrophoresis. By examining these images, we identified changes in the nucleotides in these specific regions. To clarify fragments polymorphisms, the PCR products were sequenced with an Applied Biosystems Automated Sequencer. We observed the Arg188His polymorphism of XRCC2 genes in 42.2%, as shown in 30 of the 71 cancer patients. Only 21 out of 86 controls showed this polymorphism (24.2%). We also observed that 21 of the 71 patients (29.5%) carried the RAD51135G/C polymorphism of this gene. The same polymorphism was observed in 11 of the 86 controls (12.7 %; p < 0.05). The obtained results indicate that the polymorphism of RAD51 and XRCC2 genes may be associated with the incidence of colon cancer in the Turkish population. Further studies, including those on a larger group of patients, are required to further clarify this point.

Entities:  

Keywords:  Colon cancer; RAD51; Turkey; XRCC2 genes; polymorphism

Year:  2015        PMID: 25932214      PMCID: PMC4402861     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation.

Authors:  C S Griffin; P J Simpson; C R Wilson; J Thacker
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.

Authors:  Jiali Han; Susan E Hankinson; Hardeep Ranu; Immaculata De Vivo; David J Hunter
Journal:  Carcinogenesis       Date:  2003-10-24       Impact factor: 4.944

3.  Polymorphisms of the BRCA2 and RAD51 genes in breast cancer.

Authors:  Tomasz Sliwinski; Renata Krupa; Ireneusz Majsterek; Jan Rykala; Agnieszka Kolacinska; Zbigniew Morawiec; Jozef Drzewoski; Marek Zadrozny; Janusz Blasiak
Journal:  Breast Cancer Res Treat       Date:  2005-11       Impact factor: 4.872

4.  Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.

Authors:  Karen A Pooley; Caroline Baynes; Kristy E Driver; Jonathan Tyrer; Elizabeth M Azzato; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

5.  Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.

Authors:  Susana N Silva; Marta Tomar; Claudia Paulo; Bruno Costa Gomes; Ana Paula Azevedo; Valdemar Teixeira; Julieta Esperança Pina; José Rueff; Jorge Francisco Gaspar
Journal:  Cancer Epidemiol       Date:  2009-12-09       Impact factor: 2.984

6.  XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; Robert A Wolff; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

7.  Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.

Authors:  Karen Curtin; Wei-Yu Lin; Rina George; Mark Katory; Jennifer Shorto; Lisa A Cannon-Albright; Gillian Smith; D Timothy Bishop; Angela Cox; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

8.  Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.

Authors:  Jonine D Figueroa; Núria Malats; Nathaniel Rothman; Francisco X Real; Debra Silverman; Manolis Kogevinas; Stephen Chanock; Meredith Yeager; Robert Welch; Mustafa Dosemeci; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Gemma Castaño-Vinyals; Montserrat García-Closas
Journal:  Carcinogenesis       Date:  2007-06-08       Impact factor: 4.944

9.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

10.  miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.

Authors:  Kaiwu Xu; Zhihui Chen; Changjiang Qin; Xinming Song
Journal:  Onco Targets Ther       Date:  2014-02-20       Impact factor: 4.147

View more
  4 in total

1.  Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer.

Authors:  Soma Saeed; Ishrat Mahjabeen; Romana Sarwar; Kashif Bashir; Mahmood Akhtar Kayani
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

2.  XPG Asp1104His, XRCC2 Rs3218536 A/G and RAD51 135G/C Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis

Authors:  Ebrahim Eskandari; Alireza Rezaifar; Mohammad Hashemi
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

3.  Genetic Variations of RAD51 and XRCC2 Genes Increase the Risk of Colorectal Cancer in Bangladeshi Population.

Authors:  Anika Uddin Hridy; Samia Shabnaz; M D Asaduzzaman; Mohammad Shahriar; Mohiuddin Ahmed Bhuiyan; Mohammad Safiqul Islam; S M Moazzem Hossen; Talha Bin Emran
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

4.  XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer.

Authors:  Lijie Wang; Junxun Ma; Bo Yang; Fangfang Jing; Yi Hu
Journal:  Med Sci Monit       Date:  2018-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.